Colgate-Palmolive Co (NYSE:CL) recently announced a dividend of $0.5 per share, payable on 2024-05-15, with the ex-dividend date set for 2024-04-19. As investors look forward to this upcoming ...

Colgate-Palmolive's estimated fair value is US$124 based on 2 Stage Free Cash Flow to Equity Current share price of US$87.13 suggests Colgate-Palmolive is potentially 30% undervalued Analyst price ...

Colgate-Palmolive has been growing revenues and managing the challenging economic environment well with strong earnings growth. The company offers stability and reliability in a volatile market ...

In the latest market close, Colgate-Palmolive (CL) reached $86.75, with a +0.67% movement compared to the previous day. The stock's performance was ahead of the S&P 500's daily loss of 0.58%.

On Wednesday, Stifel, a financial services company, updated its outlook on Colgate-Palmolive Company (NYSE:CL), increasing the stock price target to $94 from the previous $89 while maintaining a ...

RBC Capital analyst Nik Modi maintained a Hold rating on Colgate-Palmolive (CL – Research Report) on April 17 and set a price target of $88.00. The company’s shares closed yesterday at $86.71.

Wall Street expects a year-over-year increase in earnings on higher revenues when Colgate-Palmolive (CL) reports results for the quarter ended March 2024. While this widely-known consensus outlook is ...

According to GlobalData’s company profile on Colgate-Palmolive, Nanoemulsion cosmetics was a key innovation area identified from patents. Colgate-Palmolive's grant share as of February 2024 was 63%.

Looking at the universe of stocks we cover at Dividend Channel, on 4/19/24, Colgate-Palmolive Co. (Symbol: CL), CVS Health Corporation (Symbol: CVS), and Medical Properties Trust Inc (Symbol ...

View upcoming earnings forecasts and in-depth analysis of company forecasts.